🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Viral Infection

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites📍 Johannesburg📍 Durban📍 Cape Town bioLytical Laboratories · Tests: TruPlex HIV/HepB/Syphilis Rapid Test ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV NCT06274632NA2 sites📍 Miami📍 Houston Massachusetts General Hospital · Tests: ADELANTE Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data NCT07419347n/a2 sites📍 Vancouver📍 Toronto AbbVie Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites📍 Boston📍 Clichy📍 Hong Kong Precision BioSciences, Inc. · Tests: PBGENE-HBV Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance NCT06779864n/a1 site📍 Beijing Beijing Friendship Hospital Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma NCT07538128EARLY Phase 11 site📍 Shanghai Huashan Hospital · Tests: YSCH-01, Atezolizumab (1200 mg every three weeks) Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus Levels NCT07841990Phase 22 sites📍 Ft. Pierce📍 Houston Gilead Sciences · Tests: B/F/TAF, GS-3242, Lenacapavir A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors NCT06311578Phase 110 sites📍 New York📍 Philadelphia📍 Pittsburgh Johnson & Johnson Enterprise Innovation Inc. · Tests: JNJ-87704916, Cetrelimab, Standard of Care PD(L)-1 CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL NCT06559189Phase 11 site📍 Aurora University of Colorado, Denver · Tests: CD19x22 CAR T Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360Phase 317 sites📍 Birmingham📍 Walnut Creek📍 Miami GlaxoSmithKline · Tests: MMRVNS, MMRV Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population NCT05580458Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Shingrix Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site📍 New York NYU Langone Health Unravelling the Measles Paradox (MISIA) NCT07267585n/a1 site📍 Rotterdam Erasmus Medical Center Immuno-virological Evaluation of Persons Living With HIV (PLWH) NCT05973825NA1 site📍 Ghent University Hospital, Ghent · Tests: Leucapheresis Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) NCT04301076Phase 119 sites📍 Atlanta📍 Atlanta📍 City of Saint Peters National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride Prevalence and Clinical Implications of HPV Infection in Male IBD Patients NCT05911750n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Anal pap smear and oral swab for cytology and HPV testing Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640Phase 29 sites📍 Los Angeles📍 San Francisco📍 Indianapolis New York Medical College · Tests: viral specific cytotoxic t-lymphocytes Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085Phase 3231 sites📍 Birmingham📍 Mobile📍 Anchorage Children's Oncology Group · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. NCT07670468Phase 1, Phase 21 site📍 Seoul LucasBio · Tests: LB-DTK-MV Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein NCT06441123n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood Sampling Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) Clazakizumab vs. Placebo - COVID-19 Infection NCT04494724Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: Clazakizumab, Placebo Brain Imaging in Babies Study NCT04443179n/a1 site📍 London King's College London Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 NCT06848309n/a1 site📍 St Louis Washington University School of Medicine · Tests: Bronchoscopy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy